On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) opened higher 5.69% from the last session, before settling in for the closing price of $15.9. Price fluctuations for TNXP have ranged from $6.76 to $130.00 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 73.03% over the past five years. Company’s average yearly earnings per share was noted 91.80% at the time writing. With a float of $11.77 million, this company’s outstanding shares have now reached $11.78 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.05%, while institutional ownership is 20.10%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 91.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Check out the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). In the past quarter, the stock posted a quick ratio of 9.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -986.99, a number that is poised to hit -4.17 in the next quarter and is forecasted to reach -8.61 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 18.77%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 2.40%, which indicates a significant decrease from 34.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.11 in the past 14 days, which was lower than the 2.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.76, while its 200-day Moving Average is $26.24. Nevertheless, the first resistance level for the watch stands at $17.98 in the near term. At $19.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.01. If the price goes on to break the first support level at $15.95, it is likely to go to the next support level at $15.10. The third support level lies at $13.92 if the price breaches the second support level.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are currently 8,766K shares outstanding in the company with a market cap of 197.91 million. Presently, the company’s annual sales total 10,090 K according to its annual income of -130,040 K. Last quarter, the company’s sales amounted to 2,000 K and its income totaled -28,270 K.
